- Home
- AQST vs RWAY Comparison
AQST vs RWAY Comparison
Compare AQST & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- RWAY
- Stock Information
- Founded
- AQST 2004
- RWAY 2015
- Country
- AQST United States
- RWAY United States
- Employees
- AQST N/A
- RWAY N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- RWAY
- Sector
- AQST Health Care
- RWAY
- Exchange
- AQST Nasdaq
- RWAY Nasdaq
- Market Cap
- AQST 390.4M
- RWAY 410.4M
- IPO Year
- AQST 2018
- RWAY 2021
- Fundamental
- Price
- AQST $5.84
- RWAY $10.12
- Analyst Decision
- AQST Strong Buy
- RWAY Buy
- Analyst Count
- AQST 7
- RWAY 6
- Target Price
- AQST $10.29
- RWAY $11.17
- AVG Volume (30 Days)
- AQST 3.6M
- RWAY 216.5K
- Earning Date
- AQST 11-03-2025
- RWAY 11-11-2025
- Dividend Yield
- AQST N/A
- RWAY 13.75%
- EPS Growth
- AQST N/A
- RWAY 153.06
- EPS
- AQST N/A
- RWAY 1.91
- Revenue
- AQST $44,132,000.00
- RWAY $140,975,000.00
- Revenue This Year
- AQST N/A
- RWAY N/A
- Revenue Next Year
- AQST $51.50
- RWAY N/A
- P/E Ratio
- AQST N/A
- RWAY $5.32
- Revenue Growth
- AQST N/A
- RWAY N/A
- 52 Week Low
- AQST $2.12
- RWAY $8.35
- 52 Week High
- AQST $6.43
- RWAY $11.73
- Technical
- Relative Strength Index (RSI)
- AQST 62.29
- RWAY 39.40
- Support Level
- AQST $5.47
- RWAY $9.98
- Resistance Level
- AQST $5.93
- RWAY $10.31
- Average True Range (ATR)
- AQST 0.36
- RWAY 0.21
- MACD
- AQST 0.01
- RWAY -0.01
- Stochastic Oscillator
- AQST 62.43
- RWAY 19.58
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About RWAY Runway Growth Finance Corp.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States.